Abstract
Objective:
This study aims to present Chromobacterium violaceum isolated from a pleural effusion in an indoor-outdoor cat.
Materials and Methods:
A 3-year-old male domestic shorthair cat was brought to the hospital with dyspnea. The thoracic radiographs and ultrasound showed the presence of a pleural effusion. The thoracic fluid was sent for cytological analysis, reverse transcription polymerase chain reaction (RT-PCR) for feline infectious peritonitis (FIP), and bacterial culture.
Results:
Cytological findings illustrated the protein-rich modified transudate. Albumin: globulin ratio was 0.4. RT-PCR testing for FIP was negative. The bacterial culture presented a pure growth of violet-pigmented colonies on both sheep blood agar and MacConkey agar. The isolation was identified and further confirmed as C. violaceum. The isolation was susceptible to drugs in aminoglycosides, tetracyclines, macrolides, fluoroquinolones, and sulfonamide groups.
Conclusion:
Chromobacterium violaceum, a saprophytic Gram-negative bacterium, commonly inhabits stagnant water and soil in tropical and subtropical areas. It is considered an opportunistic bacterium in both veterinary and human medicine. Although C. violaceum infection is rare, the disease is extremely fatal. In Thailand, a few cases of humans infected with C. violaceum were reported; however, the bacterial infection has never been discovered in animals. This case report highlighted a rare opportunistic infection of C. violaceumin a cat in Thailand and suggested drugs of choice for clinical treatments.
Keywords: Chromobacterium violaceum, pleural effusion, antimicrobial susceptibility profile
Introduction
Chromobacterium violaceum is a saprophytic Gram-negative rod-shaped bacterium that produces a brilliant violet pigment called violacein on both blood and MacConkey agar. It is normally found in soil and stagnant water in subtropical and tropical areas. Although infection by this organism is rare, it has caused mortality in both humans and animals. The first human case was reported in Malaysia by Sneath et al. [1]. In Thailand, a few cases of human infection were reported. Sirinavin et al. [2] reported an invasive C. violaceum infection in a 3.3-year-old child with abscesses in the lungs, liver, and spleen. Jitmuang [3] reported two cases of sepsis infection with fatal outcomes. Chromobacterium violaceum primarily enters the body through opened wounds [4,5]. It is also relatively common to get an infection by accidentally coming into contact with contaminated water or dust [6–9], either through the mouth or by inhalation. Papakhee et al. [10] reported C. violaceam isolated from a wound of a patient with an open fracture of the right forearm. Moreover, Roberts et al. [11] reported a patient who developed the infection after he had traveled to Thailand and cut his leg on the coral.
In animals, the potential pathogenicity of C. violaceum was first reported in three carabaos (Bubalus bubalis carabanesis) in the Philippines [12]. Furthermore, C. violaceum infection with serious outcomes was previously described in various species of animals, for example, red panda [13], calves [14,15], horses [16], dogs [17], swine [18], non-human primates [19], and cougars [20]. Particularly in cats, the previous report of C. violaceum infection demonstrated C. violaceum isolated from non-healing dog bite wounds [21]. Nevertheless, C. violaceum causing septicemia in cats has not been recognized before. Although no evidence of transmission between humans and animals has been reported, veterinarians should take special care in dealing with animals with a history of environmental exposure and broken skin. Moreover, the antimicrobial susceptibility profiles of saprophytic bacteria revealed the resistance to several antibiotics, including a last-resort antibiotic for humans. This should be alarming about the circulation of antimicrobial resistance genes in the environment. To the best of the author’s knowledge, this report presents the first isolation of C. violaceum from a feline pleural effusion and its antimicrobial susceptibility profile.
Materials and Methods
A 3.4 kg, 3-year-old, male, domestic shorthair cat was present at the emergency room, Kasetsart University Veterinary Teaching Hospital, Kamphaeng Saen Campus, with a history of depression, decreased appetite, and dyspnea. According to history, the symptoms persisted for 2 days before the admission. The cat had been vaccinated for the feline panleukopenia virus, and no accident was noted. The physical examination revealed mild hyperthermia (102.9° F) and approximately 5% dehydration with a capillary refill time of less than 2 sec, pink mucous membrane, and dulled left lung sound.
The following diagnostic tests were performed: thoracic radiography, ultrasonography, complete blood count (CBC), and serum biochemistry. The thoracic radiographs revealed increased dense opacity of the left lung and the presence of a pleural effusion (Fig. 1A). The opacity obscured the left heart border and left hemidiaphragm. The ultrasounds confirmed the presence of a pleural effusion with hyperechoic sediments. The thoracocentesis yielded 150 ml of thick, yellow fluid, which was submitted for cytological analyses, a reverse transcription polymerase chain reaction (RT-PCR) for feline infectious peritonitis (FIP), and bacterial culture. The thoracic radiographs after the thoracocentesis illustrated the left pleural effusion (Fig. 1B).
Figure 1. (A) Thoracic radiograph before the thoracocentesis revealed increased dense opacity of the left lung and the presence of a pleural effusion. (B) Thoracic radiograph post-thoracocentesis.
A primer set used for feline coronavirus detection by RT-PCR was 5´-TAA TGC CAT ACA CGA ACC AGC T-3´ and 5´-GTG CTA GAT TTG TCT TCG GAC ACC-3´. Thermocycling conditions consisted of 50 min reverse transcription at 45°C, 5 min incubation at 95°C followed by 33 cycles of 1 min denaturation at 95°C, 1 min primer annealing at 55°C, and 1 min for primer extension at 72°C. The 33 cycles were completed with a 5 min final extension at 72°C. The administration of broad-spectrum antibiotics with amoxicillin clavulanic acid (20 mg/kg [PO] q 12 h) was employed pending the antibiotics susceptibility testing. Meloxicam (0.1 mg/kg subcutaneous [SC] q 72 h) was prescribed as an anti-inflammatory drug. To correct the dehydration, normal saline NSS [IV] was administered. The cat was followed up 3 days after the first visit, in which the clinical signs persisted. The second thoracocentesis yielded 125 ml of similar thick, yellow fluid.
Results
A CBC revealed decreased hemoglobin and mild normochromic normocytic regenerative anemia with reticulocytosis, leukocytosis, and hyperproteinemia (Table 1). Cytological findings of pleural effusion revealed protein-rich modified transudate with a total nucleated cell count of 1.06 × 103 cells/μl and a specific gravity of 1.042 (Fig. 2). The total protein of the effusion was 6 gm/dl with the albumin and globulin concentration of 1.7 and 3.90 gm/dl, respectively [albumin:globulin (A:G) ratio = 0.4].
Table 1. Hematology profiles.
| Hematology | Result | Reference range |
|---|---|---|
| White blood cell | 26.07 | 5.50–19.50 × 103 (cells/μl) |
| Neutrophils | 20.86 | 2.50–12.50 × 103 (cells/μl) |
| Lymphocytes | 3.65 | 1.50–7.0 × 103 (cells/μl) |
| Monocytes | 1.56 | 0.10–1.50 × 103 (cells/μl) |
| Eosinophils | Rare | Rare |
| Basophils | Rare | Rare |
| Hemoglobin | 8.9 | 9.80–15.40 (gm/dl) |
| Hematocrits | 28.9 | 30.00–45.00 (%) |
| Reticulocyte % | 0.96 | 0.00–0.06 (%) |
| Protein | 9 | 6.0–8.0 (gm/dl) |
Figure 2. Cytological findings of the thoracic fluid showed non-degenerate neutrophils admixed with foamy macrophages on the prominent eosinophilic stippling granular background.

The result of RT-PCR testing for FIP of the pleural effusion was negative. The culture of the thoracic fluid revealed a pure growth of smooth, round, convex, and violet-pigmented colonies on both sheep blood agar and MacConkey agar (Fig. 3A and B) after an aerobic incubation at 37°C for 24 h. Gram stain revealed Gram-negative rod-shaped bacteria (Fig. 3C). The biochemical tests were performed, and the biochemical characteristics are shown in Table 2. The triple sugar iron (TSI) test revealed the alkaline slant and acid bottom (K/A) without the production of gas and hydrogen sulfide, which was indicative of dextrose fermentation. The sim motility test showed the diffuse zone of growth expanding from the inoculation line, which indicated the positive motility test. The urease test and indole test indicated that the organism did not express the urease enzyme and tryptophanase enzyme, respectively. The lysine was not decarboxylated. The fermentation test of arabinose, mannitol, lactose, salicin, raffinose, and sucrose was negative, but the fermentation of glucose was positive. According to the appearance on the medium and biochemical characteristics, the suspected organism was identified as C. violaceum. The identification was further confirmed using a matrix-assisted laser desorption ionization-time of flight mass spectrometer (MALDI-TOF MS; VITEK® MS, bioMérieux®). The result of characteristic protein fingerprints confirmed C. violaceum (Fig. 4). Antimicrobial susceptibility tests were performed using the Kirby-Bauer disc diffusion method, and the results are shown in Table 3. The organism was susceptible to drugs in aminoglycosides, tetracyclines, macrolides, fluoroquinolones, and sulfonamide groups.
Figure 3. The appearance of C. violaceum colonies on sheep blood agar (A) and MacConkey agar (B). (C) Gram stain showed Gram-negative rod-shaped bacteria.

Table 2. Biochemical characteristics of C. violaceum.
| Biochemical test | Results |
|---|---|
| TSI | K/A without hydrogen sulfide production |
| SIM | + |
| Urea | - |
| Indole | - |
| Lysine | - |
| Arabinose | - |
| Mannitol | - |
| Lactose | - |
| Salicin | - |
| Raffinose | - |
| Sucrose | - |
| Glucose | + |
+ = Positive, - = Negative.
Figure 4. Chromobacterium violaceum was identified with a confidence value of 99.9 by MALDI-TOF MS.
Table 3. Antimicrobial susceptibility profiles.
| Class | Antimicrobial agent | Results |
|---|---|---|
| Aminoglycoside | Amikacin | S |
| Gentamicin | S | |
| Kanamycin | S | |
| Neomycin | S | |
| Streptomycin | S | |
| Penicillin | Amoxicillin + clavulanic acid | R |
| Amoxycillin | R | |
| Ampicillin | R | |
| Cloxacillin | R | |
| Penicillin | R | |
| Cephalosporin | Cephalotin | R |
| Cephalexin | R | |
| Ceftriaxone (third generation) | R | |
| Polymycin | Colistin | R |
| Lincosamide | Clindamycin | R |
| Lincomycin | R | |
| Tetracyclines | Doxycyclin | S |
| Oxytetracycline | S | |
| Macrolides | Erythromycin | S |
| Fluoroquinolones | Enrofloxacin | S |
| Nitromidazole | Metronidazole | R |
| Sulfonamide | Sulfamethoxazole + Trimethoprim | S |
R = Resistant, S=susceptible.
Discussion
This case report herein presents C. violaceum isolated from the pleural effusion of a cat presented at the veterinary teaching hospital with dyspnea and severe pleural effusion. Chromobacterium violaceum is an opportunistic Gram-negative rod-shaped bacterium commonly found in subtropical and tropical environments. In Thailand, a few cases of C. violaceum infection have been reported in humans; however, infection in animals has never been addressed before. Chromobacterium infection could start with a local infection, which could rapidly disseminate to multiple organs, causing abscesses and septicemia. Previous studies found pleuropneumonia in various animals [13,14,16–18]. In this case, the clinical findings in the cat were similar to previous publications. The characteristics of the effusion revealed protein-rich modified transudate with A:G ratio of 0.4. The culture of the effusion revealed pure isolation of C. violaceum, which was presumably responsible for the pleural effusion. Although FIP was considered as a primary differential diagnosis based on cytological findings of the transudate, this report highlights other differential diagnoses, particularly C. violaceum, which should be considered as one possibility causing protein-rich modified transudate effusion.
In general, the routes of infection in both humans and animals are either by direct contact or an oral route [14]. Nevertheless, the infection associated with water aspiration during drowning was also reported [22]. In our case, the portal of entry could not be definitively confirmed. The cat lived primarily indoors, but it was able to roam around outside, according to the owner. We speculated that the most likely point of entry could have been direct contact via broken skin or puncture wounds and contaminated with the environment. Although the external examination found no skin lesions and there was no history of trauma, the wound could have been very small, or the external wound could have been healed and could not be grossly recognized. Moreover, there was a possibility that the cat could have gotten infected while drinking or choking on contaminated water.
Due to a rare incidence of C. violaceum infection and no reported pathognomonic lesions, the diagnostic methods and bacteria identification were very challenging. The diagnosis of infection was based on the characteristic of violet pigment production on both sheep blood and MacConkey media, accompanied by biochemical tests (Table 2). To confirm the identification, MALDI-TOF MS posed a promising technology for definitive diagnosis, reducing the turnaround time and the cost for biochemical reagents [23].
Since the infection by C. violaceum is frequently associated with fatal outcomes in both humans and animals, early treatment with proper antibiotics was critical. To cover the use of antibiotics in different animal species, 10 different groups of antimicrobials were performed for the susceptibility test. The antimicrobial susceptibility profile was similar to previous publications [17]. The isolate was susceptible to aminoglycosides, tetracyclines, macrolides, fluoroquinolones, and sulfonamides. However, it was alarming that the bacterium commonly found in the environment was resistant to penicillin, cephalosporin, polymyxin, lincosamide, and nitroimidazole. The susceptibility test of C. violaceum isolated in this study revealed that cephalosporin did not affect the microorganism, implying that it is a cephalosporin-resistant strain. This study is similar to Nam et al. [24], who mentioned this phenomenon in C. violaceum isolated from a human case. Moreover, the isolate revealed resistance to colistin, which is considered a last-resort antibiotic used in humans. This finding was consistent with the findings of Alisjahbana et al. [25], who reported a low proportion (22.2%) of C. violaceum susceptible to colistin.
In this case, regarding the gross appearance of the pleural fluid, the broad-spectrum antibiotic amoxicillin + clavulanic acid was chosen to alleviate secondary infections while pending the antimicrobial susceptibility test. Unfortunately, the result of the antimicrobial susceptibility test was delayed because of the rare incidence of C. violaceum infection in the cat. As a result, the administration of amoxicillin + clavulanic acid was not discontinued, and the patient was then lost to follow-up.
Conclusion
This report presented the first C. violaceum infection in animals in Thailand. It is considered an opportunistic bacterium in both veterinary and human medicine. The isolation was susceptible to drugs in aminoglycosides, tetracyclines, macrolides, fluoroquinolones, and sulfonamide groups. The presence of this case is a significant public health concern, particularly as these animals can act as reservoirs for pathogens with the potential to infect immunocompromised individuals, which can cause the transmission of zoonotic pathogens.
Acknowledgment
The authors thank Kasetsart University Veterinary Teaching Hospital, Kamphaeng Saen Campus, and Kamphaeng Saen Veterinary Diagnostic Center staff members, Faculty of Veterinary Medicine, for their hard work and for dedicating the time to provide quality testing and good services in this case.
List of abbreviations
A:G, albumin:globulin; °C, degree Celsius; CBC, Complete blood count; dl, deciliter; FIP, Feline infectious peritonitis; gm, grams; h, hour; kg, kilogram; MALDI-TOF MS, matrix assisted laser desorption ionization-time of flight mass spectrometer; mg, milligram; min, minutes; ml, milliliter; RT-PCR, Reverse transcription polymerase chain reaction; sec, seconds; μl, microliter.
Conflict of interest
The authors declare that they have no conflict of interest.
Authors’ contributions
ND was involved in the physical examination and sample collection. SK, SC, and MS were involved in microbiological testing. PE was involved in the interpretation of the pathological finding. AA took part in the interpretation of microbiological findings and in preparing this manuscript.
References
- [1].Sneath PHA, Whelan JPF, Singh RB, Edwards D. Fatal infection by Chromobacterium violaceum. Lancet. 1953;2:276–7. doi: 10.1016/s0140-6736(53)91132-5. https://doi.org/10.1016/S0140-6736(53)91132-5. [DOI] [PubMed] [Google Scholar]
- [2].Sirinavin S, Techasaensiri C, Benjaponpitak S, Pornkul R, Vorachit M. Invasive Chromobacterium violaceum infection in children: case report and review. Pediatr Infect Dis J. 2005;24(6):559–61. doi: 10.1097/01.inf.0000164761.81491.3f. https://doi.org/10.1097/01.inf.0000164761.81491.3f. [DOI] [PubMed] [Google Scholar]
- [3].Jitmuang A. Human Chromobacterium violaceum infection in Southeast Asia: case reports and literature review. Southeast Asian J Trop Med Public Health. 2008;39(3):9. [PubMed] [Google Scholar]
- [4].Zhang P, Li J, Zhang YZ, Li XN. Chromobacterium violaceum infection on lower limb skin: a case report. Medicine. 2021;100(6):e24696. doi: 10.1097/MD.0000000000024696. https://doi.org/10.1097/MD.0000000000024696. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Alim R, Safiullah SA, Munwar S, Mazhar I, Zaman SU, Bari MS. Wound infection caused by Chromobacterium violaceum: a case report from a tertiary care hospital in Bangladesh. Adv Microbiol. 2022;12(2):83–9. https://doi.org/10.4236/aim.2022.122007. [Google Scholar]
- [6].Mazumder R, Sadique T, Sen D, Mozumder P, Rahman T, Chowdhury A, et al. Agricultural injury-associated Chromobacterium violaceum infection in a Bangladeshi farmer. Am J Trop Med Hyg. 2020;103(3):1039–42. doi: 10.4269/ajtmh.20-0312. https://doi.org/10.4269/ajtmh.20-0312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Klenk C, Schnieders M, Heinemann M, Wiegard C, Büttner H, Ramharter M, et al. Severe systemic Chromobacterium violaceum infection: a case study of a German long-term resident in French guyana. Trop Med Infect Dis. 2024;9(10):242. doi: 10.3390/tropicalmed9100242. https://doi.org/10.3390/tropicalmed9100242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].Enrico M, Baggi MF, Luigia E, Mattia L. Chromobacterium violaceum bacteraemia: a new entity in Switzerland. Swiss Med Wkly. 2020;150:w20220. doi: 10.4414/smw.2020.20220. https://doi.org/10.4414/smw.2020.20220. [DOI] [PubMed] [Google Scholar]
- [9].Takeda S, Tanaka Y, Maeda M, Hayakawa H, Mitsuya S, Yamauchi K. The first fatal case of Chromobacterium violaceum infection in Japan. Am J Case Rep. 2021;22:e932037. doi: 10.12659/AJCR.932037. https://doi.org/10.12659/AJCR.932037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10].Papakhee P, Kaewmafai N, Sararatthanachot B. Case study of Chromobacterium violaceum infection among patients at department of female orthopaedic, Mahasarakham Hospital. Mahasarakham Hosp J. 2018;15(1):108–9. [Google Scholar]
- [11].Roberts SA, Morris AJ, McIvor N, Ellis-Pegler R. Chromobacterium violaceum infection of the deep neck tissues in a traveler to Thailand. Clin Infect Dis. 1997;25(2):334–5. doi: 10.1086/516913. https://doi.org/10.1086/516913. [DOI] [PubMed] [Google Scholar]
- [12].Woolley PG. Manila, Philippines: Bureau of Public Printing; 1904. Report on Bacillus violaceous Manilae: a pathogenic microorganism; pp. 1–15. [Google Scholar]
- [13].Dyer NW, Krogh DF, DeVold R, Wilson SL, White DG. Chromobacteriosis in a Chinese red panda (Ailurus Fulgens Styani) J Vet Diagn Invest. 2000;12(2):177–9. doi: 10.1177/104063870001200217. https://doi.org/10.1177/104063870001200217. [DOI] [PubMed] [Google Scholar]
- [14].Ajithdoss DK, Porter BF, Calise DV, Libal MC, Edwards JF. Septicemia in a neonatal calf associated with Chromobacterium violaceum. Vet Pathol. 2009;46(1):71–4. doi: 10.1354/vp.46-1-71. https://doi.org/10.1354/vp.46-1-71. [DOI] [PubMed] [Google Scholar]
- [15].Soares RL, Neto NBD, Guizelini CC, Araújo MA, Leal CRB, Möck TBM, et al. Chromobacteriosis (Chromobacrterium violaceum) in a calf from Brazil—case report. Arq Bras Med Vet Zootec. 2019;71(6):5. https://doi.org/10.1590/1678-4162-11063. [Google Scholar]
- [16].Hammerschmitt ME, Rolim VM, Snel GGM, Siqueira FM, Driemeier D, Pavarini SP. Chromobacterium violaceum infection in a horse. J Comp Pathol. 2017;156(4):334–8. doi: 10.1016/j.jcpa.2017.02.004. https://doi.org/10.1016/j.jcpa.2017.02.004. [DOI] [PubMed] [Google Scholar]
- [17].Crosse PA, Soares K, Wheeler JL, Cooke KL, Adin CA, O’Kelley JJ, et al. Chromobacterium violaceum infection in two dogs. J Am Anim Hosp Assoc. 2006;42(2):154–9. doi: 10.5326/0420154. https://doi.org/10.5326/0420154. [DOI] [PubMed] [Google Scholar]
- [18].Liu CH, Chu RM, Weng CN, Lin YL, Chi CS. An acute pleuropneumonia in a pig caused by Chromobacterium violaceum. J Comp Pathol. 1989;100(4):459–63. doi: 10.1016/0021-9975(89)90013-3. https://doi.org/10.1016/0021-9975(89)90013-3. [DOI] [PubMed] [Google Scholar]
- [19].Liu DX, Didier PJ, Plauche GB. Chromobacterium violaceum infections in 13 non-human primates. J Med Primatol. 2012;41(2):107–14. doi: 10.1111/j.1600-0684.2011.00529.x. https://doi.org/10.1111/j.1600-0684.2011.00529.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20].Mesquita MCSR, Moreira JMAR, Nogueira BS, Morgado T, Ribeiro M, Colodel EM, et al. Sepsis in cougar (Puma concolor) associated with Chromobacterium violaceum. Braz J Microbiol. 2021;52(3):1611–5. doi: 10.1007/s42770-021-00460-z. https://doi.org/10.1007/s42770-021-00460-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [21].Zaini SS, Yusoff AAM, Chan WY. Chromobacterium violaceum infection in a domestic shorthaired cat with dog bite wounds. Pertanika J Trop Agric Sci. 2024;47(1):8. https://doi.org/10.47836/pjtas.47.1.09. [Google Scholar]
- [22].Ponte R, Jenkins SG. Fatal Chromobacterium violaceum infections associated with exposure to stagnant waters. Pediatr Infect Dis J. 1992;11(7):583–6. doi: 10.1097/00006454-199207000-00013. https://doi.org/10.1097/00006454-199207000-00013. [DOI] [PubMed] [Google Scholar]
- [23].Cherkaoui A, Hibbs J, Emonet S, Tangomo M, Girard M, Francois P, et al. Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level. J Clin Microbiol. 2010;48(4):1169–75. doi: 10.1128/JCM.01881-09. https://doi.org/10.1128/JCM.01881-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [24].Nam BV, Hà BT, Thúy ĐT, Doorn HR, Huy BV. Clinical presentation and treatment of 2 patients with infection caused by Chromobacterium violaceum in Vietnam. BMC Infect Dis. 2024;24:508. doi: 10.1186/s12879-024-09390-1. https://doi.org/10.1186/s12879-024-09390-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [25].Alisjahbana B, Debora J, Susandi E, Darmawan G. Chromobacterium violaceum: a review of an unexpected scourge. Int J Gen Med. 2021;14:3259–70. doi: 10.2147/IJGM.S272193. https://doi.org/10.2147/IJGM.S272193. [DOI] [PMC free article] [PubMed] [Google Scholar]


